Cipher Pharmaceuticals Inc. (CPHRF)

Cipher Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22	17.84	39.83	28.84	20.55	9.14
Cash & Short-Term Investments	22	17.84	39.83	28.84	20.55	9.14
Cash Growth	-47.59%	-55.21%	38.11%	40.34%	124.76%	44.06%
Accounts Receivable	11.77	13.86	5.09	6.8	6.66	9.22
Receivables	11.77	13.86	5.09	6.8	6.66	9.22
Inventory	5.54	5.79	2.98	2.15	1.65	0.89
Prepaid Expenses	0.84	1	0.38	0.37	0.47	0.88
Total Current Assets	40.15	38.48	48.27	38.16	29.33	20.13
Property, Plant & Equipment	0.6	0.68	0.4	0.48	0.5	1.91
Goodwill	17.45	17.45	15.71	15.71	15.71	15.71
Other Intangible Assets	77.01	78.75	1.76	2.75	3.65	4.18
Long-Term Deferred Tax Assets	27.52	26.76	19.89	16.67	2.47	2.36
Long-Term Deferred Charges	0.35	0.39	-	-	-	-
Total Assets	163.07	162.51	86.03	73.78	51.65	44.28
Accounts Payable	5.3	5.87	4.6	4.11	5.56	4.29
Accrued Expenses	-	-	-	-	-	2.53
Current Portion of Leases	0.27	0.28	0.09	0.1	0.06	0.14
Current Income Taxes Payable	0.05	0.05	-	4.9	6.23	2.65
Current Unearned Revenue	11.64	13.31	0.56	0.26	0.45	0.31
Other Current Liabilities	0.33	0.36	-	-	-	0.01
Total Current Liabilities	17.59	19.87	5.25	9.37	12.29	9.92
Long-Term Debt	40	40	-	-	-	-
Long-Term Leases	0.25	0.3	0.26	0.33	0.46	1.71
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	57.83	60.17	5.51	9.7	12.75	11.63
Common Stock	27.77	27.68	18.01	17.72	18.12	18.7
Additional Paid-In Capital	6.71	6.53	5.76	5.36	5.09	5.06
Retained Earnings	80.28	77.65	66.27	50.52	25.2	18.4
Comprehensive Income & Other	-9.51	-9.51	-9.51	-9.51	-9.51	-9.51
Shareholders' Equity	105.24	102.34	80.52	64.08	38.9	32.64
Total Liabilities & Equity	163.07	162.51	86.03	73.78	51.65	44.28
Total Debt	40.51	40.58	0.35	0.43	0.52	1.85
Net Cash (Debt)	-18.51	-22.74	39.47	28.41	20.03	7.29
Net Cash Growth	-	-	38.95%	41.81%	174.67%	-
Net Cash Per Share	-0.72	-0.90	1.55	1.10	0.75	0.27
Filing Date Shares Outstanding	26.24	25.61	23.99	25.08	25.68	26.85
Total Common Shares Outstanding	26.24	25.6	23.99	25.06	25.94	26.97
Working Capital	22.56	18.61	43.02	28.79	17.03	10.21
Book Value Per Share	4.01	4.00	3.36	2.56	1.50	1.21
Tangible Book Value	10.78	6.14	63.05	45.62	19.54	12.76
Tangible Book Value Per Share	0.41	0.24	2.63	1.82	0.75	0.47
Machinery	-	0.2	0.13	0.13	0.13	0.27
Leasehold Improvements	-	0.1	0.09	0.07	-	0.75

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.